National Guideline Clearinghouse | AHRQ Evidence Reports

National Guideline Clearinghouse | AHRQ Evidence Reports

Technology Assessment Reports

The technology assessment program at AHRQ provides technology assessments for the Centers for Medicare & Medicaid Services (CMS). These technology assessments are used by CMS to inform its national coverage decisions for the Medicare program as well as provide information to Medicare carriers. For a list of archived reports from 1990-2002, visit the AHRQ Web site . The AHRQ Web site also provides a list of Technology Assessments In Progress .
*Not available electronically. Contact AHRQTAP@ahrq.hhs.gov for report availability.
**Report is completed, but in the process of being prepared for posting. Please check back for updates.
***PDF Help: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader® .
2011

• Outcomes of Sipuleucel-T Therapy

2010

• Bone Morphogenetic Protein: the State of the Evidence of On-Label and Off-Label Use
• Consideration of Evidence on Antiemetic Drugs for Nausea and Vomiting Associated with Chemotherapy or Radiation Therapy in Adults
• Diagnosis and Treatment of Secondary Lymphedema
• ECG-based Signal Analysis Technologies
• Genetic Tests for Non-cancer Diseases/Conditions: a Horizon Scan
• Quality, Regulation and Clinical Utility of Laboratory-developed Tests
• Comparative Evaluation of Radiation Treatments for Clinically Localized Prostate Cancer: an update
• Report on the Evidence Regarding Off-Label Indications for Targeted Therapies used in Cancer Treatment
• A Systematic Review of Loss-of-Heterozygosity Based Topographic Genotyping with PathfinderTG®***
• Systematic Reviews on Selected Pharmacogenetic Tests for Cancer Treatment: CYP2D6 for Tamoxifen in Breast Cancer, KRAS for anti-EGFR antibodies in Colorectal Cancer, and BCR-ABL1 for Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia

2009

• Reviews of Selected Pharmacogenetic Tests for Non-Cancer and Cancer Conditions

2008

• Evaluation of the Evidence on Benefits and Harms of Pulmonary Artery Catheter Use in Critical Care Settings
• Home Testing in Management of Chronic Diseases
• Horizon Scan of Invasive Interventions for Lower Extremity Peripheral Artery Disease and Systematic Review of Studies Comparing Stent Placement to Other Interventions
• Horizon Scan: Lipoprotein Subfractions for Identifying Patients at Increased Risks for Cardiovascular Diseases
• Methodological Issues in Evaluation of Innovative Training Approaches to Stroke Rehabilitation
• Non-Pharmacological Interventions for Post-Discharge Care in Heart Failure
• Positron Emission Tomography for Nine Cancers (Bladder, Brain, Cervical, Kidney, Ovarian, Pancreatic, Prostate, Small Cell Lung, Testicular)

2007

• Applicability of the Evidence Regarding Intensive Glycemic Control and Self-Monitored Blood Glucose to Medicare Patients with Type 2 Diabetes
• Compendia for Coverage of Off-Label Uses of Drugs and Biologics in an Anticancer Chemotherapeutic Regimen
• Cost-Effectiveness of DNA Stool Testing to Screen for Colorectal Cancer
• Decompression Therapy for the Treatment of Lumbosacral Pain
• Esophageal Doppler Ultrasound-based Cardiac Output Monitoring for Real-Time Therapeutic Management of Hospitalized Patients
• Genetic Tests for Non-Cancer Diseases/Conditions: A Horizon Scan
• Home Diagnosis of Obstructive Sleep Apnea-Hypopnea Syndrome
• Obstructive Sleep Apnea-Hypopnea Syndrome: Modeling Different Diagnostic Strategies
• Remote Cardiac Monitoring